Table 3.
Test performed on number of samples | Sensitivity % (95% CI) |
Specificity % (95% CI) |
Overall accuracy % |
|
---|---|---|---|---|
All samples (n = 274) | ||||
Microscopy | 166 | 22 (9–42) | 95 (90–98) | 83 |
Culture | 252 | 62 (41–80) | 100 (98–100) | 96 |
PCR (1-step PCR and n-PCR pooled) | 87 | 44 (26–65) | 100 (94–100) | 83 |
Xpert Ultra | 48 | 57 (18–90) | 98 (87–100) | 92 |
MPT64 test | 274 | 32 (17–51) | 84 (79–88) | 78 |
Lymph node biopsies (n = 24) | ||||
Microscopy | 19 | 17 (0–64) | 92 (64–100) | 68 |
Culture | 20 | 33 (4–78) | 100 (77–100) | 80 |
PCR (1-step PCR and n-PCR pooled) | 15 | 29 (4–71) | 100 (63–100) | 67 |
Xpert Ultra | 2 | N/A | 100 (16–100) | – |
MPT64 test | 24 | 43 (10–82) | 100 (80–100) | 83 |
All biopsies (n = 88) | ||||
Microscopy | 63 | 20 (4–48) | 94 (83–99) | 76 |
Culture | 68 | 50 (23–77) | 100 (93–100) | 90 |
PCR (1-step PCR and n-PCR pooled) | 57 | 37 (16–62) | 100 (91–100) | 79 |
Xpert Ultra | 10 | N/A | 90 (56–100) | – |
MPT64 test | 88 | 37 (16–62) | 99 (92–100) | 85 |
Lymph node aspirates (n = 11) | ||||
Microscopy | 9 | 43 (10–82) | 50 (1–99) | 44 |
Culture | 9 | 71 (29–96) | 100 (16–100) | 78 |
PCR (1-step PCR and n-PCR pooled) | 9 | 67 (22–96) | 100 (29–100) | 78 |
Xpert Ultra | 5 | 75 (19–99) | 100 (3–100) | 80 |
MPT64 test | 11 | 29 (4–71) | 50 (7–93) | 36 |
Pus samples (n = 15) | ||||
Microscopy | 15 | 0 (0–84) | 77 (46–95) | 67 |
Culture | 15 | 50 (1–99) | 100 (75–100) | 93 |
PCR (1-step PCR and n-PCR pooled) | 6 | 100 (3–100) | 100 (48–100) | 100 |
Xpert Ultra | 10 | 50 (1–99) | 100 (63–100) | 90 |
MPT64 test | 15 | 50 (1–99) | 69 (39–91) | 67 |
Fluid samples (n = 160) | ||||
Microscopy | 79 | 0 (0–71) | 100 (95–100) | 96 |
Culture | 160 | 100 (29–100) | 100 (98–100) | 100 |
PCR (1-step PCR and n-PCR pooled) | 15 | 0 (0–98) | 100 (77–100) | 93 |
Xpert Ultra | 23 | 0 (0–98) | 100 (85–100) | 96 |
MPT64 test | 160 | 0 (0–71) | 80 (72–86) | 78 |
Abbreviations: PCR, polymerase chain reaction; CI, confidence interval